Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rosacea | 3 | 2019 | 45 | 1.280 |
Why?
|
| Dermatology | 5 | 2019 | 163 | 1.100 |
Why?
|
| Skin Care | 3 | 2019 | 13 | 0.900 |
Why?
|
| Skin Diseases | 2 | 2019 | 142 | 0.730 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2019 | 2 | 0.700 |
Why?
|
| Mandible | 1 | 2019 | 39 | 0.680 |
Why?
|
| Head | 1 | 2019 | 51 | 0.670 |
Why?
|
| Ribs | 1 | 2019 | 44 | 0.660 |
Why?
|
| Telemedicine | 1 | 2019 | 102 | 0.610 |
Why?
|
| Plant Extracts | 2 | 2018 | 61 | 0.610 |
Why?
|
| Hypericum | 1 | 2014 | 2 | 0.480 |
Why?
|
| Herb-Drug Interactions | 1 | 2014 | 2 | 0.480 |
Why?
|
| Phytotherapy | 1 | 2014 | 38 | 0.470 |
Why?
|
| Complementary Therapies | 1 | 2014 | 80 | 0.430 |
Why?
|
| Humans | 24 | 2020 | 32005 | 0.330 |
Why?
|
| Arthritis, Psoriatic | 1 | 2009 | 25 | 0.320 |
Why?
|
| Physician's Role | 1 | 2009 | 40 | 0.320 |
Why?
|
| Affect | 1 | 2009 | 69 | 0.320 |
Why?
|
| Fibromyalgia | 1 | 2009 | 25 | 0.320 |
Why?
|
| Ultraviolet Therapy | 1 | 2009 | 40 | 0.320 |
Why?
|
| Office Visits | 1 | 2009 | 73 | 0.310 |
Why?
|
| Ambulatory Care | 1 | 2009 | 108 | 0.300 |
Why?
|
| Pain | 1 | 2009 | 288 | 0.270 |
Why?
|
| Eye Abnormalities | 1 | 2006 | 4 | 0.270 |
Why?
|
| Pterygium | 1 | 2006 | 4 | 0.270 |
Why?
|
| Skin Neoplasms | 2 | 2019 | 214 | 0.230 |
Why?
|
| Medication Adherence | 3 | 2010 | 161 | 0.230 |
Why?
|
| Dermatitis, Atopic | 3 | 2010 | 102 | 0.220 |
Why?
|
| Transients and Migrants | 1 | 2006 | 290 | 0.210 |
Why?
|
| Forehead | 1 | 2020 | 13 | 0.180 |
Why?
|
| Adult | 8 | 2019 | 9345 | 0.180 |
Why?
|
| Skin Pigmentation | 1 | 2019 | 26 | 0.170 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 45 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2006 | 940 | 0.170 |
Why?
|
| Commerce | 1 | 2019 | 43 | 0.170 |
Why?
|
| Acne Vulgaris | 2 | 2010 | 96 | 0.160 |
Why?
|
| Administration, Cutaneous | 1 | 2019 | 116 | 0.160 |
Why?
|
| Internet | 1 | 2019 | 195 | 0.150 |
Why?
|
| Patient Compliance | 2 | 2010 | 225 | 0.150 |
Why?
|
| Wound Healing | 1 | 2018 | 185 | 0.150 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 44 | 0.150 |
Why?
|
| United States | 3 | 2014 | 3939 | 0.140 |
Why?
|
| Pellagra | 1 | 2016 | 3 | 0.130 |
Why?
|
| Hand Dermatoses | 1 | 2016 | 10 | 0.130 |
Why?
|
| Exanthema | 1 | 2016 | 21 | 0.130 |
Why?
|
| Erythema | 1 | 2016 | 26 | 0.130 |
Why?
|
| Psoriasis | 2 | 2013 | 360 | 0.120 |
Why?
|
| Male | 9 | 2020 | 19165 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 918 | 0.120 |
Why?
|
| Prescriptions | 1 | 2014 | 12 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 185 | 0.120 |
Why?
|
| Antidepressive Agents | 1 | 2014 | 74 | 0.120 |
Why?
|
| Dermatologic Agents | 1 | 2017 | 229 | 0.110 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 881 | 0.110 |
Why?
|
| Specialization | 1 | 2013 | 31 | 0.110 |
Why?
|
| Pruritus | 1 | 2013 | 47 | 0.110 |
Why?
|
| African Americans | 1 | 2019 | 1425 | 0.100 |
Why?
|
| Sleep | 1 | 2013 | 92 | 0.100 |
Why?
|
| Fluocinonide | 1 | 2010 | 11 | 0.090 |
Why?
|
| Clindamycin | 1 | 2010 | 22 | 0.090 |
Why?
|
| Pemphigus | 1 | 2010 | 8 | 0.090 |
Why?
|
| Tretinoin | 1 | 2010 | 34 | 0.090 |
Why?
|
| Quality of Life | 3 | 2013 | 946 | 0.090 |
Why?
|
| Eczema | 1 | 2010 | 13 | 0.090 |
Why?
|
| Depression | 1 | 2013 | 444 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2010 | 146 | 0.080 |
Why?
|
| Patient Care Planning | 1 | 2010 | 58 | 0.080 |
Why?
|
| Rheumatology | 1 | 2009 | 9 | 0.080 |
Why?
|
| Sunbathing | 1 | 2009 | 6 | 0.080 |
Why?
|
| Relaxation | 1 | 2009 | 9 | 0.080 |
Why?
|
| Rheumatic Diseases | 1 | 2009 | 7 | 0.080 |
Why?
|
| Behavior, Addictive | 1 | 2009 | 32 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2013 | 313 | 0.080 |
Why?
|
| Antirheumatic Agents | 1 | 2009 | 29 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2009 | 62 | 0.080 |
Why?
|
| Arthralgia | 1 | 2009 | 33 | 0.080 |
Why?
|
| Pigmentation Disorders | 1 | 2008 | 8 | 0.080 |
Why?
|
| Fatigue | 1 | 2009 | 85 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3509 | 0.080 |
Why?
|
| Female | 8 | 2020 | 19959 | 0.080 |
Why?
|
| Health Surveys | 1 | 2009 | 196 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2010 | 183 | 0.080 |
Why?
|
| Pediatrics | 1 | 2010 | 155 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2020 | 3306 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 324 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2009 | 141 | 0.070 |
Why?
|
| Pain Measurement | 1 | 2009 | 350 | 0.070 |
Why?
|
| Self Care | 1 | 2008 | 144 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 545 | 0.070 |
Why?
|
| Middle Aged | 5 | 2013 | 11817 | 0.070 |
Why?
|
| North Carolina | 2 | 2008 | 1514 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2006 | 124 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 767 | 0.060 |
Why?
|
| Croton | 1 | 2018 | 2 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 525 | 0.040 |
Why?
|
| Child | 3 | 2010 | 2438 | 0.040 |
Why?
|
| Aged | 3 | 2013 | 10301 | 0.030 |
Why?
|
| Surgery, Plastic | 1 | 2013 | 27 | 0.030 |
Why?
|
| Otolaryngology | 1 | 2013 | 17 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 58 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2013 | 54 | 0.030 |
Why?
|
| Adolescent | 2 | 2010 | 3539 | 0.030 |
Why?
|
| General Surgery | 1 | 2013 | 88 | 0.030 |
Why?
|
| Gels | 1 | 2010 | 31 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 781 | 0.020 |
Why?
|
| Remission Induction | 1 | 2010 | 84 | 0.020 |
Why?
|
| Mycophenolic Acid | 1 | 2010 | 41 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 898 | 0.020 |
Why?
|
| Prednisone | 1 | 2010 | 61 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 130 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2010 | 140 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 288 | 0.020 |
Why?
|
| Lentigo | 1 | 2008 | 4 | 0.020 |
Why?
|
| Vitiligo | 1 | 2008 | 4 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2008 | 44 | 0.020 |
Why?
|
| Melanosis | 1 | 2008 | 15 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 560 | 0.020 |
Why?
|
| Hyperpigmentation | 1 | 2008 | 17 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 35 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2009 | 59 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2008 | 24 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2008 | 70 | 0.020 |
Why?
|
| Biological Therapy | 1 | 2008 | 20 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2008 | 97 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2008 | 119 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 7541 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 217 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 392 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 271 | 0.020 |
Why?
|
| Asthma | 1 | 2008 | 259 | 0.020 |
Why?
|
| Prevalence | 1 | 2008 | 981 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 2149 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 1817 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 2636 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2008 | 2282 | 0.010 |
Why?
|